Home › Alzeca Biosciences' ADx Imaging Technology Shows Positive Results In Early Detection Of Alzheimer's
 

Keywords :   


Alzeca Biosciences' ADx Imaging Technology Shows Positive Results In Early Detection Of Alzheimer's

2016-06-13 07:00:28| drugdiscoveryonline News Articles

Alzeca Biosciences announced successful preliminary preclinical results for ADx, its innovative, proprietary diagnostic imaging technology, designed to enable diagnosis of Alzheimer’s disease a decade or more before the onset of symptoms of cognitive decline

Tags: results technology shows early

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Registration Now Open for RadTech 2025
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 7A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
More »